Francesco Paolucci, a health economist at the University of Newcastle, said investments by governments to deal with COVID pushed up bulk-billing rates, and he found the framing of the argument ...

In recent weeks, top health officials have floated an idea for bringing down prescription drug costs in the United States: ...